title: Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice.
abstract: Recombinant adeno-associated virus (rAAV) vectors can mediate long-term stable transduction in various target tissues. However, with rAAV serotype 2 (rAAV2) vectors, liver transduction is confined to only a small portion of hepatocytes even after administration of extremely high vector doses. In order to investigate whether rAAV vectors of other serotypes exhibit similar restricted liver transduction, we performed a dose-response study by injecting mice with beta-galactosidase-expressing rAAV1 and rAAV8 vectors via the portal vein. The rAAV1 vector showed a blunted dose-response similar to that of rAAV2 at high doses, while the rAAV8 vector dose-response remained unchanged at any dose and ultimately could transduce all the hepatocytes at a dose of 7.2 x 10(12) vector genomes/mouse without toxicity. This indicates that all hepatocytes have the ability to process incoming single-stranded vector genomes into duplex DNA. A single tail vein injection of the rAAV8 vector was as efficient as portal vein injection at any dose. In addition, intravascular administration of the rAAV8 vector at a high dose transduced all the skeletal muscles throughout the body, including the diaphragm, the entire cardiac muscle, and substantial numbers of cells in the pancreas, smooth muscles, and brain. Thus, rAAV8 is a robust vector for gene transfer to the liver and provides a promising research tool for delivering genes to various target organs. In addition, the rAAV8 vector may offer a potential therapeutic agent for various diseases affecting nonhepatic tissues, but great caution is required for vector spillover and tight control of tissue-specific gene expression.
authors.affiliation: Department of Pediatrics, Stanford University School of Medicine, Stanford, California 94305, USA. nakaih@stanford.edu
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Nakai
authors.forename: Sally
authors.initials: S
authors.lastname: Fuess
authors.forename: Theresa A
authors.initials: TA
authors.lastname: Storm
authors.forename: Shin-ichi
authors.initials: S
authors.lastname: Muramatsu
authors.forename: Yuko
authors.initials: Y
authors.lastname: Nara
authors.forename: Mark A
authors.initials: MA
authors.lastname: Kay
mesh_terms: D000818:Animals; D000229:Dependovirus / Q000145:classification* / Q000235:genetics* / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005822:Genetic Vectors; D022781:Hepatocytes / Q000821:virology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009928:Organ Specificity; D011995:Recombination, Genetic; D012703:Serotyping; D014161:Transduction, Genetic; D001616:beta-Galactosidase / Q000235:genetics / Q000378:metabolism
chemical_list: D001616:beta-Galactosidase